Evidence map›Paper›PMID 35538552›Full record

ArticleMicrobiome2022

Should we modulate the neonatal microbiome and what should be the goal?

Niels van Best, Maria Gloria Dominguez-Bello, Mathias W Hornef, Eldin Jašarević, Katri Korpela, Trevor D Lawley

Abstract readLetter
In one paragraph

Article in Microbiome, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Neonatal Microbiome: Is it Still Beneficial?Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  6. Review and Perspectives onMicroorganisms · 2023
    Review
  7. Review
  8. Article
  9. Beneficial Effects ofFrontiers in pediatrics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Niels van BestInstitute of Medical Microbiology, RWTH University Hospital Aachen, Aachen, Germany. n.vanbest@maastrichtuniversity.nl.
Maria Gloria Dominguez-BelloDepartments of Biochemistry and Microbiology and of Anthropology, and Institute for Food, Nutrition and Health, Rutgers University, New Brunswick, NJ, USA. mg.dominguez-bello@rutgers.edu.
Mathias W HornefInstitute of Medical Microbiology, RWTH University Hospital Aachen, Aachen, Germany. mhornef@ukaachen.de.
Eldin JašarevićDepartment of Computational and Systems Biology, Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, PA, Pittsburgh, USA. jasarevice@mwri.magee.edu.
Katri KorpelaHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. katri.korpela@helsinki.fi.
Trevor D LawleyWellcome Sanger Institute and Microbiotica, Cambridge, UK. tl2@sanger.ac.uk.

Funding

Immune and developmental actions of the maternal microbial metabolites on the hypothalamusK01DK121734 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JASAREVIC, ELDIN · 2020 to 2023
$555k
NIDDK NIH HHS K01 DK121734
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaGoals

Identifiers

PMID35538552
PMCPMC9087991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.